drugset / Trial / NCT04005079
Pilocarpine After Combined Cataract/Trabectome Surgery
RandomizedParallel-groupOpen-labelTreatment
Summary
Combined cataract + trabectome surgery is a surgery designed to help lower the intraocular pressure (pressure in the eye) and hopefully reduce the need for topical drops, progression of glaucoma, and/or further glaucoma surgeries. The purpose of this study is to assess whether using pilocarpine, a medication which is FDA approved to induce miosis, (in other words cause the pupil to constrict or become smaller) provides additional benefit to the success of Trabectome and cataract surgery.
Timeline
- Start
- 2019-06-05
- Primary completion
- 2021-01-21
- Completion
- 2021-01-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pilocarpine | Unknown | 2 % | — |
| Background | Ofloxacin | Small molecule | — | — |
| Background | Prednisolone | Other / unclassified | — | — |